Morpholines Stocks List Ranked for 2024 | NYSE,

	Symbol	Grade	Name	% Change
	KRON	F	Kronos Bio, Inc.	1.05
	INCY	F	Incyte Corporation	0.17

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
IDNA	D	iShares Genomics Immunology and Healthcare ETF	3.79
FBT	D	First Trust Amex Biotech Index Fund	2.97
BIS	B	ProShares UltraShort Nasdaq Biotechnology	2.09
BBH	D	Market Vectors Biotech ETF	1.84
BBP	D	BioShares Biotechnology Products Fund	1.73

Compare ETFs

Compare BIS to BBH Compare IDNA to BBP Compare IDNA to BIS

Date	Stock	Title
Apr 24	KRON	Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 24	INCY	Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
Apr 23	INCY	Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
Apr 23	INCY	Incyte (INCY) Earnings Expected to Grow: Should You Buy?
Apr 23	INCY	Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
Apr 23	INCY	Incyte to acquire immune-focused drug developer Escient
Apr 23	INCY	Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists

Morpholines: Morpholine is an organic chemical compound having the chemical formula O(CH2CH2)2NH. This heterocycle features both amine and ether functional groups. Because of the amine, morpholine is a base; its conjugate acid is called morpholinium. For example, treating morpholine with hydrochloric acid makes the salt morpholinium chloride.
The naming of morpholine is attributed to Ludwig Knorr, who incorrectly believed it to be part of the structure of morphine.